Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
NCT07167160
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Immunochemotherapy
Interventions
DRUG:
Camrelizumab combined with chemotherapy
Sponsor
Women's Hospital School Of Medicine Zhejiang University